"Mutation Status of KRAS, BRAF, PIK3CA and Expression Level of AREG and EREG Identify Responders to Cetuximab in a Large Panel of Patient Derived Colorectal Carcinoma Xenografts of All Four UICC Stages"
written by Paulina Pechańska, M. Becker, T. Mayr, B. Hinzmann, H.-P. Adams, I. Klaman, K.-H. Kretschmar, K. Kretschmar, K. Stecker, R. Mantke, R. Pauli, J. Pertschy, K. Hertel, K. Ridwelski, K. Hellwig, M. Pross, C. Radke, I. Fichtner, J. Hoffmann, A. Rosenthal,
published by Journal of Cancer Therapy, Vol.4 No.2, 2013
has been cited by the following article(s):
  • Google Scholar
  • CrossRef